Tenax Therapeutics Achieves Major Milestone as USPTO Grants
Once granted, this patent will provide intellectual property protection until December 2040, and may qualify for additional U.S. patent term extension...
Source: globenewswire.com
Page 2 - Stuart Rich News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Stuart Rich. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Stuart Rich Today - Breaking & Trending Today
Tenax Therapeutics Provides 2023 Business Update
Company to prioritize the clinical development of TNX-103 (oral levosimendan) for the treatment of pulmonary hypertension and heart failure with preserved ejection fraction (PH-HFpEF)PH-HFpEF affects more
Source: finanznachrichten.de
Tenax Announces Issuance of U.S. Patent Covering Use of IV Levosimendan in Pulmonary Hypertension with Heart Failure with Preserved Ejection Fraction (PH-HFpEF)
PH-HFpEF affects more than 1,600,000 North Americans, with estimates indicating a prevalence of more than 2,000,000 patients by 2030
Source: dicardiology.com
SUDS' Arracket: They did it all
MILFs. Sandworms. Arguably incestuous love triangles mediated by shotgun. Arracket did it all. Co-writers Bella Wellstead and Amelia Vogelsang’s promise of…
Source: honisoit.com
Tenax Granted Notice of Allowance for U.S. Patent
Patent is expected to provide additional intellectual property protection until 2040 Prevalence estimates indicate that PH-HFpEF affects over 1,500,000...
Source: globenewswire.com